BioRestorative Therapies, Inc. (BRTX)
1.54
+0.04
(+2.67%)
USD |
NASDAQ |
Nov 13, 09:56
BioRestorative Therapies Free Cash Flow (Quarterly) : -3.808M for March 31, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -3.808M |
| December 31, 2025 | -2.495M |
| September 30, 2025 | -2.901M |
| June 30, 2025 | -2.694M |
| March 31, 2025 | -2.815M |
| December 31, 2024 | -2.360M |
| September 30, 2024 | -1.758M |
| June 30, 2024 | -1.900M |
| March 31, 2024 | -2.318M |
| December 31, 2023 | -1.658M |
| September 30, 2023 | -1.191M |
| June 30, 2023 | -1.313M |
| March 31, 2023 | -2.439M |
| December 31, 2022 | -1.791M |
| September 30, 2022 | -1.427M |
| June 30, 2022 | -1.389M |
| March 31, 2022 | -1.704M |
| December 31, 2021 | -1.176M |
| September 30, 2021 | -0.6294M |
| June 30, 2021 | -0.7418M |
| March 31, 2021 | -0.8137M |
| December 31, 2020 | -0.5721M |
| September 30, 2020 | -0.5231M |
| June 30, 2020 | -0.4204M |
| March 31, 2020 | -0.4486M |
| Date | Value |
|---|---|
| December 31, 2019 | -1.811M |
| September 30, 2019 | -1.717M |
| June 30, 2019 | -1.446M |
| March 31, 2019 | -1.980M |
| December 31, 2018 | -1.553M |
| September 30, 2018 | -1.353M |
| June 30, 2018 | -1.053M |
| March 31, 2018 | -1.158M |
| December 31, 2017 | -1.363M |
| September 30, 2017 | -0.5092M |
| June 30, 2017 | -0.766M |
| March 31, 2017 | -1.219M |
| December 31, 2016 | -1.068M |
| September 30, 2016 | -1.236M |
| June 30, 2016 | -1.079M |
| March 31, 2016 | -1.808M |
| December 31, 2015 | -1.102M |
| September 30, 2015 | -0.7922M |
| June 30, 2015 | -0.8693M |
| March 31, 2015 | -0.842M |
| December 31, 2014 | -0.8011M |
| September 30, 2014 | -0.8337M |
| June 30, 2014 | -0.9532M |
| March 31, 2014 | -0.8067M |
| December 31, 2013 | -0.775M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Myriad Genetics, Inc. | -8.60M |
| CareDx, Inc. | 11.10M |
| Natera, Inc. | 5.252M |
| Exagen, Inc. | -2.771M |
| Sera Prognostics, Inc. | -7.432M |